Alpha 2.0
Login Register
» Articles » PMID: 28629907

The Role of Biosimilar Manufacturers in Improving Access to Insulin Globally

Overview
Journal Lancet Diabetes Endocrinol
Specialty Endocrinology
Date 2017 Jun 21
PMID 28629907
Citations 8
Authors
Christophe Perrin
Margaret Ewen
David Beran
Affiliations
Soon will be listed here.
Citing Articles

Availability and pricing of insulin and related diagnostics in South Africa.

Bayat S, Perumal-Pillay V, Suleman F J Pharm Policy Pract. 2024; 17(1):2372467.

PMID: 39015751 PMC: 11251433. DOI: 10.1080/20523211.2024.2372467.

Optimizing Excipient Properties to Prevent Aggregation in Biopharmaceutical Formulations.

King T, Humphrey J, Laughton C, Thomas N, Hirst J J Chem Inf Model. 2023; 64(1):265-275.

PMID: 38113509 PMC: 10777730. DOI: 10.1021/acs.jcim.3c01898.

The insulin market reaches 100.

Beran D, Gale E, Yudkin J Diabetologia. 2022; 65(6):931-935.

PMID: 35275238 PMC: 8915140. DOI: 10.1007/s00125-022-05680-y.

A global perspective on the issue of access to insulin.

Beran D, Lazo-Porras M, Mba C, Mbanya J Diabetologia. 2021; 64(5):954-962.

PMID: 33483763 PMC: 8012321. DOI: 10.1007/s00125-020-05375-2.

[Insulin: prices, availability, and affordability in public and private Peruvian pharmaciesPreço, disponibilidade e acessibilidade à insulina em farmácias públicas e privadas no Peru].

Tenorio-Mucha J, Lazo-Porras M, Hidalgo-Padilla L, Beran D, Ewen M Rev Panam Salud Publica. 2019; 43:e85.

PMID: 31768180 PMC: 6822689. DOI: 10.26633/RPSP.2019.85.